care Archives

April = Donate Life Month

April 1, 2013 by BNMCin Campus-wide, Community, Homepage, Member Institution(s)1 Comment

Unyts kicks off April, Donate Life Month, with a schedule of events to bring awareness to the importance of organ, eye and tissue donations.

On Friday, April 5, at 9, 9:30 and 10 p.m., Niagara Falls will light up in green to show support for the efforts that will come this month, helping to bring about more awareness.
On April 6, the Peace Bridge will commemorate Donate Life Month by exuding green and blue lights on the bridge.
In its second year, the Bucket List Bash will commence at Statler City on April 12. Much like The Bucket List movie, the event will celebrate life, the ambitions and goals yet to be accomplished, offering many the opportunity to enjoy an evening doing what they have always dreamed of. Learn more about these events here.
To show your Unyts pride, on April 19, dress in your most outrageous blue and green. As an alternative to dressing in blue and green, you and your colleagues can decorate your company’s office space. When you share your blue and green photos on the Unyts Facebook page, you can be entered for a chance to win a signed Hodgson Sabres jersey.

Every person registered as a donor has the opportunity to help save a life. Regardless of age, race, or medical history, anyone can become a donor. Every organ and tissue donation goes to the person with the most need, no matter their socio-economic status. With more than 115,000 people on the national waiting list to receive organ, eye and tissue transplants that may either enhance or save their lives, the call to register is important. The response, though, is what will make a difference. Unfortunately, with more than 300,000,000 million people living in the United States, the need for donors is still greater than the supply.

According to Unyts, nearly 800 people in Western New York are waiting for lifesaving organs. Every 10 minutes, 1 person is added to the national transplant list. Visit the Donate Life Registry website and become a donor today. During the month of April, each presenting donor can receive a FREE 6-inch or Flatbread Breakfast Sandwich from any Subway in Buffalo. For more information, click here.

You can help give the gift of life.

Roswell Park's Center for Personalized Medicine

January 31, 2013 by BNMCin Campus-wide, Community, Health care, Member Institution(s), News, Research1 Comment

Roswell Park Cancer Institute‘s (RPCI) new 5,000-square-foot facility, the Center for Personalized Medicine (CPM), will provide individualized therapies for patients through genetic code sequencing (an analysis of genomes – the entire inherited genetic makeup of humans). Using state-of-the-art, next-generation technology, advanced research has led to the identification of unique genetic characteristics that will help determine effective and custom treatments for patients with certain diseases. Utilizing high-throughput screening for drug discovery, personal gene sequence machines and a 1,600-processor supercomputing cluster, the RPCI team will efficiently be able analyze individual genome data.
Located within RPCI’s Center for Genetics & Pharmacology, the Center will also act as a resource for scientists and medical providers to use for national clinical care wp-contentlication. In addition to having a mobile unit, the CPM is the first regional resource for next-generation gene sequencing to have met federal Clinical Laboratory Improvement Amendments (CLIA) requirements.

At the end of last year, RPCI was awarded a $5.1 million grant to begin the pilot phase of the genome project from Governor Cuomo’s Regional Economic Development Council, established to promote regional economic development. Since then, RPCI has garnered an additional $18.5 million in investments to support the project. From RPCI, $16 million has been invested in equipment and infrastructure, and Computer Task Group (CTG), a Buffalo-based national leader in healthcare IT, has committed to $2.5 million. As a local and nearby partner, CTG will provide its healthcare and bioinformatics expertise to deliver personalized medicine quickly and cost-effectively. The University at Buffalo, IMMCO Diagnostics and Western New York Urology Associates LLC are additional supporters of the project.

Candace Johnson, PhD, Deputy Director of the CPM stated that “We now have the ability to do robust, ‘next-generation’ gene sequencing on blood and tissue samples, with tremendous possibilities in terms of what we can learn diagnostically, prognostically, therapeutically.” Johnson also stated that personalized medicine is the future, not just for oncology patients but for treatments across all diseases.

The CPM is a prime example of the type of support that Cuomo’s Council looks to provide for organizations throughout the region to capitalize on resources and developments that will support the local economy by creating more jobs and economic growth. Recognizing the growth hwp-contentening on the Buffalo Niagara Medical Campus and throughout the region, Cuomo stated that “Western New York has a thriving health and life sciences industry cluster, which the Western New York Regional Economic Development Council and Roswell Park Cancer Institute recognized. Through the Regional Council process, they created a custom-tailored plan to take advantage of this opportunity, which will rebuild the regional economy.”

RPCI’s President and CEO, Dr. Donald Trump captured the significance of the Center’s presence. He stated that “The doors are wide open in terms of the opportunities for entrepreneurship and technology transfer that will flow from [the Center].” The CPM team, partners and supporters increase RPCI’s menu of services, giving the institution the opportunity to contend with other small circle healthcare organizations providing similar medical services.

Immediately on the agenda, the CPM will undertake its first 3 sequencing projects, clinical research studies that will:

Predict on a case-by-case, personalized basis which of the two main types of standard chemotherapy, anthracycline-based or platinum-based, will be most effective in treating a woman’s breast cancer, and with fewest adverse side effects;

Develop, in collaboration with Western New York Urology Associates, a diagnostic test for superficial bladder cancer, the ninth most common cancer in the U.S. and the most expensive of all cancers in terms of cost to treat; and
Engage 600 healthy volunteers representing the ethnic, racial, socioeconomic and geographic diversity of the eight-county Western New York region in an initiative to identify the particular healthcare priorities of this community, aided by a mobile tissue-collection unit that will travel to disparate and underserved areas.
In addition, RPCI expects to use the resources of the CPM in planning individualized care for its lung, melanoma and leukemia patients in the near future.

New Vaccine Research Aims to Prevent Recurrent Ear Infections

January 7, 2013 by BNMCin Homepage, Life Sciences Companies, Member Institution(s), News3 Comments

Lab in UB’s Clinical and Translational Research Center is one of few in the world studying an increasingly prevalent bacterium, once considered harmless
Children’s ear infections cause more than pain and sleepless nights; they temporarily disrupt hearing when children are at a critical age for speech and language development. They also have major social and economic costs.

But while infants and children receive immunizations against infections caused by Haemophilus influenzae and pneumococcus, there is no vaccine against Moraxella catarrhalis, an increasingly prevalent bacterium that causes at least ten percent of otitis media cases.

Now, University at Buffalo scientists, among just a handful of researchers in the world studying this organism, have received a $1.5 million National Institutes of Health (NIH) grant to develop a vaccine against it. The researchers are among the first tenants in UB’s Clinical and Translational Research Center, which opened in September on the Buffalo Niagara Medical Campus.

The goal of the current research, funded by the NIH’s National Institute on Deafness and Other Communication Disorders, is to identify new virulence mechanisms for this understudied pathogen, identify the structure of a candidate antigen for a new vaccine and develop a new vaccine.

According to Timothy F. Murphy, MD, SUNY Distinguished Professor of Medicine and Microbiology in the UB School of Medicine and Biomedical Sciences and principal investigator on the NIH grant, research on M. catarrhalis has lagged because it was originally believed to be a “commensal” or harmless bacterium. While it does cause milder cases of middle ear infections (otitis media) than other bacteria, Murphy said it is becoming more prevalent. Preliminary evidence also shows that existing ear infection vaccines are changing colonization patterns among otitis media pathogens, possibly increasing the prevalence of M. catarrhalis infections.

“Of the 15 to 20 million cases of otitis media each year in the U.S., about ten percent are recurring, causing incredible disruption for the child and the family,” explains Murphy. “When a child has the infection, the middle ear fills with fluid, a condition that can last for a month or longer. During that time, the child’s hearing is muffled, which disrupts the normal development of language and speech skills, potentially resulting in long term delays and learning problems in school.”

Recurrent ear infections also require repeated courses of antibiotics, which then contribute to the global problem of antibiotic resistance. Some children must undergo insertion of drainage tubes under general anesthesia.

“The best option would be to prevent these infections in the first place,” says Murphy.

The goal of the UB researchers is to identify M. catarrhalis antigens that are very similar among all strains so that a vaccine based on a single antigen will protect against as many strains of the bacterium as possible.

“Based on our results thus far, it looks like we will be able to identify antigens that are identical or very similar among all strains and genetic lineages,” says Murphy.

He and his colleagues are using bioinformatics to identify genes predicted to encode proteins on the surface of the organism, construct a gene chip to test which of more than 300 possible genes on the surface are identical or similar among multiple strains and then clone genes for some of the predicted proteins for testing in in vitro and mouse models.

The UB group is now testing several promising vaccine antigens that they have identified. A new vaccine could be ready for human testing in three to five years.

Murphy and his colleagues at UB are global leaders in the study of M. catarrhalis in otitis media in children and chronic obstructive pulmonary disease (COPD) exacerbations in adults. Their hope is that the same vaccine could be used to prevent both kinds of infections.

In addition to directing the M. catarrhalis research, Murphy directs UB’s Clinical and Translational Research Center and is senior associate dean for clinical and translational research in the UB medical school. For more than a decade, Murphy has studied how M. catarrhalis causes both otitis media in children and infections in chronic obstructive COPD in adults.

Ellen Goldbaum (UB); goldbaum@buffalo.edu; 716.645.4605

Molecule Inhibitor, CFAK-Y15, Could Treat Certain Brain Cancers

January 3, 2013 by BNMCin Homepage, Member Institution(s), Research2 Comments

Researchers from Roswell Park Cancer Institute (RPCI) have published findings from a preclinical study assessing the effectiveness of a small-molecule inhibitor, CFAK-Y15, in treating some brain cancers. The paper, published in Molecular Cancer Therapeutics, demonstrates for the first time that inhibiting the protein focal adhesion kinase (FAK) with CFAK-Y15 is an effective wp-contentroach to controlling growth of glioblastoma tumors, especially in combination with the standard chemotherapy agent temozolomide (Temodar).
FAK is overexpressed, or produced in excessive amounts, in tumor cells, and has been shown to play a key role in survival of cancer cells. In this study, a team led by Vita M. Golubovskaya, PhD, an Associate Professor of Oncology in the Department of Surgical Oncology, found that animal models treated with CFAK-Y15 demonstrated significantly prolonged survival compared to the control group. CFAK-Y15 provides FAK kinase-specific inhibition by upstream targeting of autophosphorylation sites on the FAK protein. It belongs to a class of ‘two for one’ compounds that also inhibit the oncoprotein Src by inhibiting its autophosphorylation.

“We found that CFAK-Y15 significantly decreased the viability of the glioblastoma cells, and in many cases wp-contenteared to cause tumor shrinkage — especially when CFAK-Y15 was given in combination with temozolomide,” noted Dr. Golubovskaya, the paper’s first author. “These compounds target FAK signaling, which is critical for cancer cell and cancer stem cell survival, especially in invasive and metastatic cancers.”

“We’re eager to see this research move to the clinical phase because of the great need for more effective treatments for glioblastoma,” noted senior author William G. Cance, MD, FACS, Surgeon-in-Chief and Chair of the Department of Surgical Oncology. “The potential impact is great because glioblastomas are such an aggressive tumor, and because we know they produce FAK in especially high quantities.”

The authors also included researchers from the University of California at San Diego and faculty from the Department of Pathology at RPCI. CFAK-Y15 is being developed by CureFAKtor Pharmaceuticals LLC (www.curefaktor.com). Drs. Cance and Golubovskaya, both of whom also serve on the management team of CureFAKtor, were part of the team that first identified CFAK-Y15, in research published in the Journal of Medicinal Chemistry in 2008.

The new abstract and paper, “Pharmacological blockade of FAK autophosphorylation decreases human glioblastoma tumor growth and synergizes with temozolomide,” can be accessed online at http://mct.aacrjournals.org/content/early/2012/12/12/1535-7163.MCT-12-0701.

This work was supported by Susan Komen for the Cure Foundation grant BCTR0707148 and three National Cancer Institute (NCI) grants: R01CA065910, R01HL073396, and the NCI’s Cancer Center Support Grant for Roswell Park Cancer Institute (P30CA016056).

Annie Deck-Miller, RPCI Senior Media Relations Manager; annie.deck-miller@roswellpark.org; 716-845-8593

Pharmacy Opens on the BNMC, Serves Entire Community

December 13, 2012 by BNMCin Campus-wide, Community, Innovation Center, Wellness2 Comments

Mobile Pharmacy Solutions (MPS), located in the Innovation Center at 644 Ellicott Street, is a convenient pharmacy option on the Buffalo Niagara Medical Campus for the entire community. The locally owned and operated pharmacy opened its doors the first week of December. True to its name, MPS operates using a distinct pharmacy care model offering over-the-counter prescription and free delivery services for Western New Yorkers right where they are. Customers can also receive prescriptions by mail. The full-service pharmacy functions as a normal drugstore and in addition to its mobile services, MPS also provides immunizations and medical therapy management. Order by phone, online, or in-person.
The pharmacy hours are Monday – Friday, 8 a.m. – 7 p.m., and Saturday, 9 a.m. – 2 p.m. Prescriptions can be ordered by phone, online, or in-person. To speak with an MPS representative, call 716.247.5300.

MPS is dedicated to helping its customers receive the best pharmaceutical care that can be administered. Complimentary compounded medications (medications tailored to each patient’s treatment needs) are created in-house and its staff of pharmacists provide scheduled in-home and virtual consultations.

Clinics for influenza vaccinations and outpatient wellness will be conducted frequently and there are certified diabetic educators on staff. When the pharmacy is closed, patients have access to an on-call pharmacist 24/7 through an automated phone system.

Through the Courtesy Care program, refills are automatically filled using a pharmacy dispensing system. When your prescription is due, you don’t even have to worry about keeping up with expiring medication dates.

Other services include:

Adherence Services
Collaborative Consultative Services
Patient Management and Outcomes Programs
Diabetes Education and Management Program, CDE
Mobile Healthcare Connections Collaborator
Ancillary Services

Helping patients save time and the hassle of having to pick-up a prescription, MPS provides same- and next-day prescription delivery to your home or workplace. The convenient delivery service gives each individual the opportunity to focus on life’s daily to-dos as they rest assured that the pharmaceutical treatments recommended are en route.

New to MPS? Begin receiving your prescription services today and receive free glucose monitoring as a new patient. MPS accepts all Medicare part D plans and most commercial insurance plans as well. MPS has a total of 17 employees, including 6 pharmacists.

Visit www.mpswny.com to learn more.

RPCI Receives Leapfrog Top Hospital Recognition for 3rd Straight Year

December 4, 2012 by BNMCin Homepage, Member Institution(s), News3 Comments

Roswell Park Cancer Institute (RPCI) has been named to The Leapfrog Group’s annual Top Hospitals list for a third consecutive year. One of only three National Cancer Institute-designated comprehensive cancer centers in New York state, RPCI is the only New York facility to be named a Leapfrog Top Hospital for 2012.
The Leapfrog Top Hospital designation puts RPCI in a class representing less than 8% of eligible hospitals. In all, 67 urban facilities, 13 rural institutions and 12 children’s hospitals earned the designation this year. The Leapfrog Group, a coalition of public and private employers, selects hospitals for the designation based on an annual national survey measuring performance in areas such as error prevention, Intensive Care Unit staffing and complex, high-risk procedures.

“The Leapfrog Top Hospital distinction is by far the most competitive award a hospital can receive. Leapfrog holds hospitals to the highest standards on behalf of our purchaser members and their employees,” said Leah Binder, President & CEO of The Leapfrog Group. “By achieving the Top Hospital accolade, Roswell Park Cancer Institute has demonstrated exemplary performance across all areas of quality and patient safety that are analyzed on the Leapfrog Hospital Survey. This hospital stands out as one consistently providing safe, high quality care, and I would be comfortable sending my family to Roswell Park for care.”

RPCI has frequently been recognized for high-quality care and overall excellence. The Institute was again recognized in U.S. News & World Report’s 2012-13 Best Hospitals list for Cancer Care and also this year was re-certified for a three-year period by the Joint Commission, an independent accrediting body.

“We are extremely proud to receive the Leapfrog award for the third consecutive year. Roswell Park participates in a number of quality assessment programs every year — many of them, like the annual Leapfrog survey, on a voluntary basis,” said Roswell Park Medical Director Judy Smith, MD. “Through this process we can evaluate the work we do and look for opportunities for further improvement; it is an invaluable opportunity for a thorough, unbiased review by an informed outside organization.”

Annie Deck-Miller; annie.deck-miller@roswellpark.org; 716-845-8593

BHSC's Therapeutic Playground Opens for Children with the Support of Donors

November 19, 2012 by BNMCin Homepage, Member Institution(s), News2 Comments

Left to right: Joe Cozzo, President & CEO, Buffalo Hearing & Speech Center; Alexandra Wehr, Sr. Relationship Manager, KeyBank, Marie Hare, Vice President of Community Affairs, KeyBank, and Gary Quenneville, President (Western New York District), KeyBank.

Buffalo Hearing & Speech Center (BHSC) installed a new therapeutic playground after 2 years of planning and months of construction. The playground project received a supportive boost by the KeyBank Foundation. Additional support came from the Buffalo Sabres Foundation, the Rotary Club of Buffalo, the DreamCatcher Foundation, the Buffalo Bills Youth Foundation and nearly 100 other individual donors from the Western New York community.

Located at 50 East North Street on the Buffalo Niagara Medical Campus, the playground will help to stimulate the senses of the more than 200 children who attend the school. BHSC provides innovative programs and cutting edge capabilities aiding in the diagnosis and treatment of communication disorders, literacy, autism, and learning challenges.

The playground was designed by a team of physical and occupational therapists with the goal of having each piece on the playground help to meet the diverse needs of the students at BHSC in need of speech, hearing or educational services. The therapeutic playground structure consists of a large multicolored play system built on a safe rubberized surface that can accommodate the different needs of students. The new playground offers a cohesive, natural environment where children are content and comfortable while they develop social skills at a level wp-contentropriate for them. The playground offers multiple varieties of sensory play experience so that children of all abilities are able to play and learn. By supporting the sensory needs of all children, the playground enhances individual development in ways that cannot be achieved by standard methods.

Every day, students at the BHSC learn, grow, and have fun while on the campus grounds. “Play is a very important part of the childhood experience. Buffalo Hearing & Speech Center recognizes that that act of playing is where children are able to explore, discover, create and imagine, while learning about the world around them firsthand,” said Jospeh Cozzo, President and CEO of the BHSC.

BHSC offers audiology, early childhood, speech language, and pathology services, in addition to a number of specialized programs for children and adults. Learn more about BHSC:

November = Lung Cancer Awareness Month

November 6, 2012 by BNMCin Campus-wide, Community, Environment, Homepage, Member Institution(s), News, Wellness5 Comments

It is natural to think of family, food and the things one is most thankful for when November rolls around. Raising awareness for lung cancer during the month of November is important to think about as well. While only 1 out of every 10 smokers will get lung cancer, it is still the number 1 cancer killer of men and women in the country, killing nearly 150,000 people per year. It is the second-most diagnosed cancer in men and women as well.
Its cause: smoke inhalation. Smoking tobacco or any kind of drug is the highest risk factor for lung cancer. Secondhand smoke causes nearly 50,000 deaths of nonsmokers every year according to the U.S. Department of Health and Human Services. Lung cancer has increasingly become a disease that is not just associated with smokers. Other risk factors include exposure to radon, asbestos, polluted air, and an existing lung disease.

According to Roswell Park Cancer Institute (RPCI) Associate Professor of Oncology and Director of Collaborative Research in the Department of Medicine, Mary Reid, PhD, between 60% and 70% of patients with lung cancer are diagnosed too late, making surgery a non-option. As efforts increase to create more early screening options, the probability of prolonging life increases dramatically.

RPCI Lung Cancer Screening

Through its High-Risk Lung Cancer Program, RPCI offers lung cancer screening for those who meet the criteria below:

Previously treated lung, oral, throat and/or esophageal cancer
Smoking more than a pack of cigarettes a day for at least 20 years or the equivalent
Chronic lung disease, such as emphysema, chronic bronchitis or chronic obstructive lung disease (COPD)
Occupational-related asbestos disease
A family history of lung cancer in a first-degree relative
History of substantial secondhand smoke exposure

Tests used to detect lung cancer in its early stages are Bronchoscopy and Low-Dose Chest CT Scan (LDCT).

RPCI Lung Cancer Treatment

The Thoracic Lung Cancer Center at RPCI offers specialized comprehensive care for the prevention, diagnosis and treatment of lung cancer. Lung cancer patients treated at the Thoracic Center receive the the latest and most efficient treatment and surgical procedures, including Video Assisted Thoracic Surgery (VATS). VATS is a minimally invasive surgery that enables the surgeon to remove tumors in openings no bigger than 1-inch in diameter using a small video camera.

Cessation Programs

The New York State Smokers’ Quitline is free and confidential. Services include telephone counseling, a starter kit of free nicotine replacement, medications for eligible smokers, access and referrals to local smoking cessation programs and more.

RPCI offers a smoking cessation program, Just Breathe, helping smokers to quit using customized plans, in addition to providing behavioral counseling, and pharmacotherapy.

Learn more about lung cancer on RPCI’s website.

RPCI’s Mary Reid, PhD

WCHOB and RPCI Partner to Create New Pediatric Hematology Oncology Center

November 1, 2012 by BNMCin Health care, Member Institution(s), News8 Comments

Continuing efforts to create a multifaceted children’s hospital, Kaleida Health‘s Women & Children’s Hospital of Buffalo (WCHOB) and Roswell Park Cancer Institute (RPCI) have partnered to build a pediatric hematology oncology center in the new John R. Oishei Children’s Hospital.
Signing a memorandum of understanding to plan the new center today, the WCHOB and RPCI have begun the planning process for this physician-led initiative to combine their services, creating a single center of excellence for pediatric inpatient/outpatient care. The proposed Center will incorporate inpatient beds, an outpatient clinic, isolation beds for blood and bone marrow transplant/high-dose therapy patients, and infusion facilities for chemotherapy and blood products, all in a protected environment on the top floor of the new hospital.

Both institutions are two of the most prominent healthcare institutions in WNY, providing pediatric hematology-oncology services for more than forty years. Currently, WCHOB provides specialty pediatric services essential to the care of these children including surgery, anesthesia, intensive care, and diagnostic imaging. RPCI provides oncology clinical leadership and services including radiation therapy, certain highly-specialized diagnostic services, blood and marrow transplants and clinical trials. RPCI is expected hold a long-term lease for the Center and will be responsible for its medical direction. The planned Center will continue to capitalize on the unique expertise of both institutions.

“This partnership between the two organizations is an excellent example of the many opportunities the new John R. Oishei Children’s Hospital on the Buffalo Niagara Medical Campus is granting,” said Teresa Quattrin, MD, Chair, Department of Pediatrics, Professor of Pediatrics, SUNY at Buffalo, and Pediatrician-in-Chief, Chief, Division of Endocrinology-Diabetes, Women & Children’s Hospital of Buffalo. “We look forward to continuing to create this integrated Hematology & Oncology Unit to further enhance the care provided to patients and their families throughout Western New York and beyond.”

WCHOB is submitting its Certificate of Need wp-contentlication for the new hospital to the New York State Department of Health on November 2nd. RPCI anticipates to submit the Certificate of Need for the Pediatric Hematology Oncology Center by the end of the year.

“Each institution contributes unique expertise and services to children and young adults with cancer and blood disorders such as sickle cell disease, hemophilia and anemia. The new hospital presents a great opportunity to develop a true pediatric Center of Excellence,” said Martin L. Brecher, MD, Chair of Pediatrics at Roswell Park Cancer Institute, Chief of Hematology Oncology at Women & Children’s Hospital and Chief of Pediatric Hematology-Oncology in the Department of Pediatrics at the University at Buffalo.

James R. Kaskie, President and CEO of Kaleida Health stated that “Together, and in conjunction with the University at Buffalo academic programs, we will jointly operate a center of excellence for children with cancer and blood diseases where expert clinical services are provided, innovative and pioneering research is advanced to find a cure and improve treatment options, and current and future health care professionals are trained and educated.”

“Management of cancer is best provided in facilities where hospital inpatient beds and outpatient facilities are in close proximity. The relocation of the children’s hospital to the medical campus provides the opportunity to pull together what have been two physically separate outpatient and inpatient units into a single, expanded service comprehensive facility to serve the needs of children of all ages with blood diseases and cancer,” said Donald L. Trump, MD, President and CEO of RPCI.

Each institution’s respective Board of Directors recognizes that the relocation of the WCHOB to the BNMC presents a unique opportunity to take an excellent pediatric hematology oncology program and make it extraordinary by bringing all the services together in a new state-of-the-art hospital. Philanthropic support for the hospital and for the pediatric hematology oncology center will be required to make the program consolidation a reality.

The 12-story, 430,000 sq. ft. John R. Oishei Children’s Hospital is scheduled to open in 2016.

Buffalo-Area Pharmacists Say No to Tobacco Sales in Pharmacies

October 29, 2012 by BNMCin Member Institution(s), News1 Comment

FOR IMMEDIATE RELEASE
October 29, 2012
Contact: Annie Deck-Miller, Senior Media Relations Manager
716-845-8593; annie.deck-miller@roswellpark.org

Buffalo-Area Pharmacists Say No to Tobacco Sales in Pharmacies

BUFFALO — More than 75 percent of Western New York pharmacists say tobacco sales in pharmacies should be legally banned, according to research conducted by Roswell Park Cancer Institute (RPCI) and the University at Buffalo (UB), published in BMC Research Notes. The study found that more than 86% of pharmacists surveyed would prefer to work in a pharmacy that does not sell tobacco products.

The research, led by James Marshall, PhD, Senior Vice President for Cancer Prevention and Population Sciences at RPCI, evaluated the opinions of Western New York pharmacists about the sale of tobacco products in pharmacies and about their role in helping their patients to stop smoking.

“The sale of tobacco products in pharmacies in any locality sends conflicting messages to consumers who visit pharmacies for medication or health products,” said Dr. Marshall. “Pharmacists, dedicated to protecting the health of their customers, recognize tobacco sales as contrary to their professional ethics. They would, in overwhelming numbers, prefer not to be selling cigarettes. This research will inform policymakers and elected officials as they consider regulations of tobacco sales in pharmacies.”

The 2010 survey evaluated opinions of 148 pharmacy mentors from the UB School of Pharmacy and Pharmaceutical Sciences (UBSoPPS) and 345 local supervising pharmacists. Participants were contacted by mail and email. The combined response rate for both surveys was 31%.

The pharmacist’s role in assisting patients to stop smoking also was evaluated. The survey found that more than 75% of pharmacists say they “sometimes” or “rarely/never” ask about tobacco use. The majority of pharmacists also indicate that they are not required to document tobacco use among patients or to enter such information into patient records.

“A striking finding is that pharmacy mentors were more likely than supervising pharmacists to be familiar with patients’ tobacco use and take steps to offer advice and information about how to quit smoking,” said Peter Brody Jr., PharmD, Director of Experiential Education at UBSoPPS. “It was also surprising that area pharmacists seemed not to take full advantage of the opportunity to educate and counsel patients regarding tobacco use. We need to better understand why and do what we can to help correct this issue.”

“This research presents several interesting findings, including that the overwhelming majority of pharmacists would support legislation banning the sale of tobacco in pharmacies,” added Edward Bednarczyk, PharmD, Chair of the Department of Pharmacy Practice at UB. “Importantly, this study also shows a considerable gap between theory and practice, with a substantial majority of pharmacists finding the sale of tobacco in pharmacies inwp-contentropriate, but doing little to prevent the sale or engage patients regarding tobacco use and smoking cessation.”

The study, Tobacco sales in pharmacies: a survey of attitudes, knowledge and beliefs of pharmacists employed in student experiential and other worksites in Western New York,” can be accessed at http://www.biomedcentral.com/1756-0500/5/413/abstract.

The mission of Roswell Park Cancer Institute (RPCI) is to understand, prevent and cure cancer. RPCI, founded in 1898, was one of the first cancer centers in the country to be named a National Cancer Institute-designated comprehensive cancer center and remains the only facility with this designation in Upstate New York. The Institute is a member of the prestigious National Comprehensive Cancer Network, an alliance of the nation’s leading cancer centers; maintains affiliate sites; and is a partner in national and international collaborative programs. For more information, visit RPCI’s website at http://www.roswellpark.org, call 1-877-ASK-RPCI (1-877-275-7724) or email askrpci@roswellpark.org.

BMG is the 1st Physician's Group Outside of Northeast Ohio to Join Quality Alliance

October 19, 2012 by BNMCin Homepage, Member Institution(s), News2 Comments

As one of the oldest and largest multi-specialty physician groups in the state of New York, Buffalo Medical Group, P.C. is the first organization to join the Cleveland Clinic Community Physician Partnership’s Quality Alliance that is outside of northeast Ohio.
Improving the quality of care, the Quality Alliance program couples independent physicians with Cleveland Clinic physicians, aiming to implement thorough and reviewed best practices and evidence-based clinical protocols in order that the best possible care can be given to patients. Cleveland Clinic is an academic medical center that integrates clinical and hospital care with research and education.

The Cleveland Clinic Community Physician Partnership designed the network to bring about the improvement of the quality and consistency of clinical care; reduce costs and increase efficiency; and provide access to expertise, data and experience. The alliance meets these goals through physician-led review of patient care, physician-developed clinical protocols, mechanisms assuring adherence to those protocols, and common data collection and reports. With over 900 independent physician members, the Alliance is one of the third largest networks in the nation of its kind striving to standardize and improve the quality of care.

“Partnering with the Cleveland Clinic Community Physician Partnership and Quality Alliance is a logical extension of BMG’s commitment to providing exemplary care for our patients” said Irene S. Snow. M.D., Medical Director of the BMG.

Chief Medical Officer of Cleveland Clinic’s Community Physician Partnership & Quality Alliance, Tarek Elsawy, M.D., stated that “The Buffalo Medical Group is the right type of partner, as it has demonstrated through its highly engaged culture of quality and commitment to process improvement.”

BMG is committed to providing the best comprehensive care for patients, having achieved the highest level of recognition by the National Committee for Quality Assurance for Patient Centered Medical Home – the first health care provider in WNY to do so. BMG has also been recognized for its care for diabetes patients by the same committee. BMG adds more than 100 primary care, specialty care and sub-specialty physicians to the program.

'Know Your Stats' Promotes Prostate Cancer Screening for 2nd Year

October 15, 2012 by BNMCin Community, Event, Member Institution(s), WellnessLeave a Comment

Roswell Park, Buffalo Bills Team up on ‘Know Your Stats’ Awareness Campaign for Second YearAmerica’s first cancer center, Bills partner to host prostate cancer screening clinic at Ralph Wilson Stadium

One in six men will be diagnosed with prostate cancer, but with early detection, about 90 percent of these cancers will be cured. Roswell Park Cancer Institute (RPCI) and the Buffalo Bills are encouraging men over 50, or those 40 and over with risk factors such as a family history of the disease, to get informed about prostate cancer and talk with their doctor about whether early detection is right for them.

For the second consecutive year, RPCI and the Bills are hosting the Prostate Cancer Early Diagnosis Outreach Clinic, a free prostate cancer education and screening event, in connection with the American Urological Association Foundation’s Know Your Stats about Prostate Cancer® campaign. RPCI doctors will be performing free screenings that will include prostate-specific antigen (PSA) blood tests and digital rectal exams (DRE) for eligible men at the event on Tuesday, October 23rd from 4:30 p.m. to 7 p.m. at the Ralph Wilson Stadium located at 1 Bills Drive in Orchard Park.

Special wp-contentearances will be made throughout the event by the Buffalo Jills, Buffalo Bills alumni and Buffalo Bills Wide Receiver David Nelson. Tours of Ralph Wilson Stadium will be offered for attendees, who will also be eligible to win raffle prizes.

Men planning to attend the clinic should call 1-877-ASK-RPCI (1-877-275-7724) or complete the online registration form at http://www.roswellpark.org/knowyourstats. From that site, visitors can also access ads featuring Bills wide receiver David Nelson, whose father is a prostate cancer survivor.

Light-A-Life 2012 Gives the Gift of Remembrance

October 11, 2012 by BNMCin Campus-wide, Community, Fundraiser, Member Institution(s)Leave a Comment

A great way for families to memorialize a loved one that they have lost.

Every year, the holiday season presents an opportunity to give gifts to our loved ones and to those we may not even know. While the holiday season ignites feelings of charity, love, food, and family, nostalgia often arises when it is time to make new memories in the midst of remembering those of old.

The Hospice Foundation of Western New York gives individuals and families the opportunity to memorialize loved ones during the holiday season. In its 24th year, the annual Light-A-Life fundraiser serves to honor lost loved ones and to assist with the care of patients within Hospice Buffalo. Helping to keep memories alive and provide the best care for individuals with serious end-of-life illnesses, the Hospice Foundation is shooting for a $120,000 goal this year. With the overwhelming support of family and friends last year, gifts in 2011 reached $117,000. By remembering your loved one, you can help the Hospice Foundation reach this year’s goal to support patients in hospice care.

The Light-A-Life commemorative bells will be given to supporters who give a gift of $55. The porcelain bells are the 18th in a collectible series that can be remembered for future generations. The hand-painted bells by Buffalo ceramic artist Becky Plummer of Barking Spider Pottery will have your loved one’s name inscribed in the inside by a dedicated Hospice volunteer. The traditional Light-A-Life Memorial Tree lighting event will take place on Saturday, December 1st. The trees will be adorned with red, silver, gold and green bows and tags with loved ones’ names on them. The event is free and open to the public.

Additional gift levels include:

Did you know that Hospice Buffalo is the only licensed hospice program in Erie County? Hospice Buffalo places an emphasis on offering the best quality of life services to patients enduring end-of-life illnesses. Patients are guaranteed to receive holistic care that not only caters to physical needs, but to the social, psychological, emotional and spiritual needs of the patient as well. With the help of its team of doctors, nurses, social workers, spiritual advisors, and volunteers, Hospice Buffalo serves the patient and their family members, helping each to live their best lives.

To give the gift of life and honor your loved one, please visit www.community.hospicebuffalo.com/lal2012-support

On-the-Spot Mammograms and Breast Cancer Education at Patient Voices Network Event

October 8, 2012 by BNMCin Campus-wide, Community, Event, Health care, Healthy Communities, Outreach, WellnessLeave a Comment

Free wellness event and walk are sponsored by Patient Voices Network, a network of patient action teams, established by UB Family Medicine and Jericho Road Ministries
A free breast cancer awareness walk and wellness event will be held Saturday, October 13 at 10 a.m. in Masten Park by the Patient Voices Network. The network is a patient empowerment partnership between the University at Buffalo Department of Family Medicine, and patients from UBMD Family Medicine at Jefferson and Jericho Road Family Practice.

The 1.6 mile walk will start at 10 a.m. at the Best Street entrance to Masten Park, with registration starting at 8:30 a.m. The wellness event begins at 11 a.m. in Masten Park. Health care providers will be available to talk to participants and there will also be information on breast health, breast cancer and screening. Healthy snacks and free T-shirts will be distributed.

On-site screening mammograms will be available for women who have a prescription and who pre-register by calling WNY Breast Health at 1-855-464-7465, prior to the event. Free services through the Cancer Services Program are available for the uninsured. Those who are unable to get screened on Oct. 13 will be provided with an wp-contentointment for another day.

The idea for the event originated with members of the Patient Voices Network, which was formed by the UB Primary Care Research Institute of the Department of Family Medicine and Jericho Road Ministries. In the network, patients living with chronic illness work together to improve primary care and to boost the rate of cancer screenings at the network’s practice partners, Jericho Road Family Practice and UBMD Family Medicine at Jefferson, which is operated by the UB Department of Family Medicine.

“We were talking about how everyone knows what the pink ribbon means, but to really reach people on Buffalo’s East Side, we would need to put on an event right in the community,” says Laurene Tumiel-Berhalter, PhD, associate professor of family medicine and director of community translational research at the Primary Care Research Institute in UB’s School of Medicine and Biomedical Sciences. “We started talking about walking right down Jefferson Avenue, bringing people out of their homes to join us and to get screened for breast cancer.”

According to Tumiel-Berhalter, patients and providers were committed to making sure that both the walk and the event be free in order to ensure the highest possible participation rate. Those who want to donate to breast cancer research will be able to do so; gift bags for participants will include information on how to donate.

“This is not a fundraiser,” she stresses. “This is an event we are holding to educate people on the East Side about breast cancer and to screen them for it.”

The free walk and event are being made possible by grants to the Patient Voices Network from the Western New York Affiliate of Susan G. Komen for the Cure and from the New York State Division of Science, Technology and Innovation (NYSTAR).

During the event, women who have pre-registered will be screened at the WNY Breast Health’s Mobile Mammography Unit, which will be stationed in Masten Park. Additional screenings will take place on Oct. 18, when the unit will be stationed in front of UBMD Family Medicine at Jefferson and UBMD Gynecology Obstetrics, 1315 Jefferson Ave. in Buffalo.

Throughout the rest of the fall, women will have additional opportunities to receive mammograms. The unit will be stationed at Jericho Road Family Practice, 184 Barton St., Buffalo, on the fourth Tuesday of every month and at Jericho Road Family Practice, 1609 Genesee St. on the third Tuesday of every month. To pre-register, call 1-855-464-7465.

“By stationing the mammography machines in such convenient and visible locations, we hope that as many people as possible in the community will get screened,” says Tumiel-Berhalter.

If a screening indicates that further tests are necessary, patients will be referred to an wp-contentropriate health care provider if they do not already have one.

The need for breast cancer education in minority communities is urgent, says Tumiel-Berhalter, because:

–Among African-American women, breast cancer is the most common cancer and the second most common cause of death;

–African-American women have a higher incidence rate of breast cancer before age 40 and are more likely to die from it at every age than are non-Hispanic, white women;

–While mortality rates decreased for white breast cancer patients from 1975 to 2003, they actually increased for African-American women.

The Patient Voices Network began with a grant Tumiel-Berhalter received from the National Center for Minority Health and Health Disparities, part of the National Institutes of Health. She used the grant to develop an organization in which patients could promote ways to improve primary care in their community by helping one another. The response from patients was so enthusiastic that the group, which began meeting monthly, now meets on a weekly basis. The network provides education and assistance in the community for patients with diabetes and, with Roswell Park Cancer Institute, has promoted colorectal cancer events and screenings. More information on the network is here: http://www.fammed.buffalo.edu/patientvoices.

Ellen Goldbaum (UB); goldbaum@buffalo.edu; 716.645.4605; @egoldbaum

UB's Clinical & Translational Research Center Grand Opening

September 18, 2012 by BNMCin Member Institution(s), News, ResearchLeave a Comment

The University at Buffalo‘s (UB) Clinical and Translational Research Center (CTRC) has opened its doors to function as the premier center placing clinicians right next to clinical and translational researchers.
The University at Buffalo School of Medicine and Biomedical Sciences held the grand opening event at the UB-Kaleida Health joint facility located on Ellicott and Goodrich Streets on Thursday, September 20. The CTRC commenced the research collaborations to take place in the immediate future with a ceremony featuring physicians, UB representatives, and city and state officials. Speakers at the event included: Timothy F. Murphy, MD, director of UB’s CTRC and SUNY Distinguished Professor, UB School of Medicine and Biomedical Sciences; Michael E. Cain, MD, UB vice president for health sciences and dean of the UB School of Medicine and Biomedical Sciences; Jeremy M. Jacobs, chairman, UB Council; Satish K. Tripathi, PhD, UB President; Sam Hoyt, Regional President, Empire State Development Corp.; Crystal D. Peoples-Stokes, NYS Assembly; Mark Grisanti, NYS Senate; and Byron W. Brown, mayor, City of Buffalo.

A walk-through of the CTRC and a keynote address by pioneering genomics scientist J. Craig Venter, who was conferred a SUNY honorary doctorate followed the ceremony.

A 170,000 sq. ft. biomedical research facility created to lessen the interval between discovery and cure, the CTRC will allow UB’s physician scientists to do their research upstairs in the CTRC and to see patients and work with clinicians downstairs in the Gates Vascular Institute (GVI).

The CTRC was designed by Cannon Design and constructed by with significant input from UB’s researchers so as to maximize this kind of collaboration in order to catalyze medical breakthroughs and innovative treatments. UB is recruiting more world-class researchers to work within the CTRC; the facility is part of UB’s medical school, which is relocating to downtown Buffalo in 2016 under the UB 2020 plan and with the support of Governor Cuomo’s NYSUNY 2020 legislation. A Biosciences Incubator within UB’s CTRC will assist UB researchers with the commercialization of new medical therapies and technologies.

“The opening of the CTRC is an important step in the relocation of UB’s medical school to the Buffalo Niagara Medical Campus, under the UB 2020 plan and with the support of the NYSUNY 2020 legislation,” said UB President Satish K. Tripathi.

While Kaleida’s GVI occupies the first 4 floors of the facility, the CTRC is housed on floors 5 – 8 with the Jacobs Institute (which will open in October 2012) located on the 5th floor between the two. Read more about the CTRC here.

Division within WCHOB Department of Pediatrics Receives $1.1 M Grant

September 17, 2012 by BNMCin Health care, Homepage, Member Institution(s), News, WellnessLeave a Comment

The Women & Children’s Hospital of Buffalo’s (WCHOB) Division of Neonatology received a grant for $1.1 M from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. A published SUPPORT report trial revealed that there is a lack of knowledge regarding oxygen supplementation, delivery and toxicity in newborn infants. The Optimal Oxygenation in Neonatal Lung Injury grant will be used to propel the research focusing on infant oxygen supplementation.
Neonatal resuscitation is necessary when an infant is asphyxiated. When an infant is born, its pulmonary circulation shifts in order to adjust to the environment outside of the womb. When that adjustment is not flawless and is met with immediate complications, the result can be a condition called Persistent Pulmonary Hypertension of the Newborn (PPHN) which can be fatal.

Dr. Satyan Lakshminrusimha, the Chief of the Division of Neonatology and Associate Professor of Pediatrics at the University at Buffalo, is the grant’s principal investigator. His research focuses on the pathophysiology of the cardio-pulmonary transition – how fetal lungs change at birth in order to breathe air – and disorders of this transition such as birth asphyxia, PPHN, retained lung liquid and respiratory distress syndrome.

The Division’s research goals are to deliver the best critical care to infants with respiratory depression at birth and reduce oxygen toxicity; to discover the optimum management of newborns with PPHN; and to further the treatment of necrotizing enterocolitis (NEC), a gastrointestinal disease that disproportionately affects pre-term infants.

The grant’s disbursement over a 5-year period, with $235, 523 given to the Division each year will go towards the collection of physiological data that will help to establish guidelines for optimal oxygen delivery to premature infants.

The WCHOB has the region’s only level 4 unit in its Neonatal Intensive Care Unit, meaning it can provide immediate trauma care that can evaluate, diagnose, and stabilize patients, also offering a degree of surgery and critical care services. The hospital is Western New York’s center for state-of-the-art pediatric, neonatal, perinatal and obstetrical care.

Meet Rear Admiral Rebecca McCormick-Boyle During Buffalo Navy Week

September 4, 2012 by BNMCin Campus-wide, Community, Event, Health care, Member Institution(s), WellnessLeave a Comment

Community members will get the opportunity to meet Chief of Staff, U.S. Navy Bureau of Medicine and Surgery, Rear Admiral Rebecca McCormick-Boyle on Wednesday, September 12 from 3:00 – 4:00 p.m. at the Swift Auditorium at Buffalo General Medical Center. The U.S. Navy Bureau of Medicine and Surgery is the headquarters of Navy and Marine Corps medicine. The event is free and open to the public.
Rear Admiral McCormick-Boyle will address Navy Medicine’s humanitarian assistance/disaster relief efforts, emergency medicine, research and development, and wounded warrior care to key medical personnel of the Buffalo Niagara Medical Campus during a presentation in honor of Buffalo Navy Week. McCormick-Boyle will also highlight the Navy’s global mission of being forward deployed to provide a power projection and deterrence role while also being ready to respond to humanitarian assistance and disaster response requirements.

“When the world dials 911, it’s not to make an wp-contentointment,” said McCormick-Boyle. “We are a global force for good. We build our Navy for war. But we operate our Navy for peace.”

Navy Medicine consists of 63,000 personnel that provide health care support to the U.S. Navy, Marine Corps, their families and veterans in high operational tempo environments, at expeditionary medical facilities, medical treatment facilities, hospitals, clinics, hospital ships and research units around the world. Navy Medicine works closely with inter-agency, non-governmental organizations and community partners during humanitarian assistance/disaster relief missions and homeland security operations around the globe.

Palliative Care Program at Roswell Receives Advanced Certification

July 19, 2012 by BNMCin Health care, Homepage, Member Institution(s), Research, WellnessLeave a Comment

Roswell Park Cancer Institute (RCPI) has a strong, dedicated, and experienced team within its Supportive & Palliative Care Program. Most recently, the team received Advanced Certification in Palliative Care for a two-year period from The Joint Commission, an organization that accredits and certifies more than 19,000 health care organizations and programs in the United States.
Palliative Care provides care for individuals with progressive illnesses, helping patients experience relief from symptoms such as pain and the stresses that come with a serious illness. The goal of palliative care is to improve the quality of life for both the patient and the family as well as to work with the other doctors each patient has, providing an extra layer of support. At RPCI, the Supportive & Palliative Care team works with the attending physician and can join the care process at any time, including during curative treatment.

Led by Yashodhara Satchidanand, MD, and Amy Alvarez, MD, the certification makes RPCI the nation’s only dedicated cancer center. It is now also 1 of 15 national hospitals to receive advanced certification to date. “Our team was very excited about receiving the certification. This validates our work and acknowledges that RPCI is known not only for cutting-edge research, but also for compassionate care,” said Dr. Satchidanand, a staff physician and Assistant Professor with the program.

To receive this certification from The Joint Commission, palliative care programs must meet patient-oriented eligibility requirements. The care program must be provided within an accredited hospital, offering a full range of palliative care services to hospitalized patients 24 hours per day, seven days per week. The palliative care team must be easy to contact, readily available to come to the hospital to address patient and family needs when necessary, and must be able to constantly provide the same level of palliative care services around the clock, not just during business hours. Amongst having a minimum number of patients during an initial on-site review, programs must also administer a standardized method of clinical care based on clinical practice guidelines and/or evidence-based practice. To read about more of the eligibility requirements, click here.

“This certification allows us to enhance and help change the perception of palliative care as more than end-of-life care,” notes Dr. Alvarez, a physician with the Department of Supportive & Palliative Care. “It is care for the continuum of the cancer journey, focusing on the goals of the patients and their families.”

Palliative care is wp-contentropriate at any age, at any stage in a serious illness and is designed to meet the patient and family’s psychological, emotional, and physical curative needs.

Buffalo Green Code Open House Meetings

May 31, 2012 by BNMCin Community, Construction, Environment, Event, Healthy Communities, Homepage, Transportation, WellnessLeave a Comment

Buffalo Green Code open house meetings for the community will take place June 4 until June 9. Through the City of Buffalo’s new zoning ordinance, a land use plan that was created last year will be improved upon as specific and detailed laws will govern development that takes place throughout the city.
The open house meetings will offer community members the opportunity to learn more about how the zoning ordinance will work and benefit their neighborhoods. There will also be Youth and Family Sessions. The BNMC and Healthy Kids, Healthy Communities (HKHC) partners have organized and will lead the family sessions at the meetings. Healthy Kids, Healthy Communities Buffalo will help kids and parents provide input into the process and fully understand the zoning initiative.

HKHC Blog.

Visit the Buffalo G reen Code website for more information.

Community	Date	Time	Location	Address
West	Mon, 6/4	6-8:30 pm	Lafayette HS	370 Lafayette Ave.
Northwest	Tue, 6/5	6-8:30 pm	Riverside HS	51 Ontario St
South	Tue, 6/5	6-8:30 pm	South Park HS	150 Southside Pkwy.
Ellicott	Wed, 6/6	6-8:30 pm	Montessori School #32	342 Clinton St.
Northeast	Wed, 6/6	6-8:30 pm	Bennett HS	2885 Main St.
North	Thurs, 6/7	6-8:30 pm	North Park Academy	780 Parkside Ave.
Central Morning	Fri, 6/8	8-10:30 am	Central Library	1 Lafayette Square
Central Afternoon	Fri, 6/8	Noon-2:30pm	Central Library	1 Lafayette Square
E. Delavan-Masten	Sat, 6/9	9-11:30am	East HS	820 Northampton St.
East	Sat, 6/9	1-3:30pm	Matt Urban Center	1081 Broadway Pkwy.

BNMC Becomes a Tobacco-Free Zone

May 31, 2012 by BNMCin Campus-wide, Healthy Communities, News, WellnessLeave a Comment

As the Buffalo Niagara Medical Campus continues to promote healthy lifestyles and sustainable environments, on July 4 the Medical Campus will officially be declared a tobacco-free zone across its 120 acre footprint which spans from Goodell Street to North Street and east-west from Michigan Avenue to Main Street. The tobacco-free adoption wp-contentlies to all of the BNMC’s employees, visitors, patients, vendors, contractors and will not be permitted on any of the BNMC properties.
Many of the member institutions such as the Buffalo Medical Group, Kaleida Health, Roswell Park Cancer Institute, and the University at Buffalo have already declared that their sites are tobacco-free zones. Working with the Erie-Niagara Tobacco-Free Coalition, BNMC created a tobacco-free plan that included data from campus employees about their receptiveness for creating a tobacco-free campus. There was a great deal of support from many of the employees who took the survey since a major reason mentioned for choosing to work at one of the medical and research institutions was to help create healthier environments.

This adoption will affect more than 1 million patients and visitors, as well as the 12,000 employees and students. Secondhand smoke is a dangerous contributor to tobacco-related health issues. Residents that live near the BNMC will be influenced by this change as well, ceasing the litter that builds up on neighboring properties. To continue to show dedication to becoming a good neighbor promoting healthy communities, a detailed implementation strategy will be established in order to promote and enforce the initiative.

For information about tobacco cessation resources, please visit the NYS Department of Health Tobacco Control Program and the Erie-Niagara Tobacco-Free Coalition websites.

Read coverage about the adoption below:

City Hall Looks to Broaden New Tobacco Ban on Buffalo Niagara Medical Campus

Buffalo Niagara Medical Campus is Now Smoke Free

Medical Corridor Snuffs Out Smoking

Buffalo Niagara Medical Campus Going Tobacco-free

Buffalo Niagara Medical Campus to Ban Smoking

Medical Campus Wants to Expand Smoking Ban

Smoking Banned at Buffalo Niagara Medical Campus

Roswell Park Cancer Institute Unveils New ICU

April 25, 2012 by BNMCin Homepage, Member Institution(s), NewsLeave a Comment

Roswell Park Cancer Institute (RPCI) unveiled its new Intensive Care Unit (ICU) that fuses state-of-the-art technology with patient-centered design to provide optimal care for patients with the most sensitive medical needs.
The ICU is 8,000 sq. ft. and is located on the eighth floor of RPCI’s main building. It is 40% larger than the already-existing ICU, created for the specific purpose of anticipating future growth. The design of the relocated unit was based on industry best practices and extensive input from RPCI’s clinical-operations team. Laura Shoemaker, a Senior Planner from RPCI’s Facilities and Planning Department, incorporated warm, soothing earth tones, with circle and arc themes in order to help convey connectedness and comfort to the patients and visitors. An included feature in the patient rooms is the large windows which help provide natural lighting in accordance with New York State Department of Health requirements in addition to breathtaking views of the Buffalo Niagara Medical Campus and downtown Buffalo.

The floor plan allows staff to work more efficiently, promoting safety and adaptability as patient monitoring is enhanced through the multifunctional modular boom units, automated lifts and zoned lighting.

For more information, please visit the RPCI’s Web site.

Assisted Living Consultants

March 25, 2012 by BNMCin Innovation CenterLeave a Comment

Assisted Living Consultants is a consulting company that specializes in the operational and physical needs of adult living residential communities. Assisted Living Consultants serves companies needing consulting and management assistance or development in the Residential Senior Communities. The company’s expertise is in Assisted and Independent Living industries, both national and international.

Kaleida’s Gates Vascular Institute and UB's Clinical Translational Research Center Grand Opening and Ribbon Cutting

March 20, 2012 by BNMCin Homepage, Member Institution(s)Leave a Comment

The new Gates Vascular Institute (GVI) and the University at Buffalo‘s Clinical and Translational Research Center (CTRC) next to Buffalo General Medical Center grand opening and ribbon cutting will be Thursday, May 24th. Kaleida Health has designed this state-of-the-art facility to be the premier destination for stroke care, cardiac surgery, and vascular services. The brand new emergency department opened in the building in November 2011. Kaleida has consolidated services into one location, increasing its ability to provide world-class care for Western new Yorkers and beyond. Learn more about this new location.

Continue reading “Kaleida’s Gates Vascular Institute and UB's Clinical Translational Research Center Grand Opening and Ribbon Cutting”